Investment Rating - The industry investment rating is "Positive" [2] Core Insights - The report highlights that Philip Morris International (PMI) has set a three-year growth plan focusing on new tobacco products, targeting a revenue CAGR of 6%-8% and an operating profit CAGR of 8%-10% from 2026 to 2028 [3] - PMI's revenue for 2025 reached $40.65 billion, a year-on-year increase of 7.3%, with new tobacco product revenue at $16.85 billion, up 15.0% [2][3] - The report anticipates significant growth in the U.S. market, particularly with the launch of IQOS ILUMA, which is expected to stimulate the heat-not-burn (HNB) segment [3] Revenue and Market Performance - In 2025, PMI's total revenue was $40.65 billion, with Q4 revenue at $10.36 billion, reflecting a 6.8% year-on-year increase [2] - The HNB segment achieved a global market share of approximately 76%, with annual sales of 155.1 billion units, marking an 11.0% increase [4] - In Q4, HNB sales reached 38.4 billion units, a 7.5% increase year-on-year, with Japan's HNB penetration rate reaching 32.6% [4] Product Growth and Strategy - The report notes that sales of oral tobacco and vaping products increased by 18.5% and 100% year-on-year, respectively, with Q4 growth rates of 7.3% and 91.4% [5] - The U.S. oral tobacco market, particularly the ZYN brand, continues to grow rapidly, maintaining a market share close to two-thirds [5] - PMI's vaping product VEEV has launched in 47 markets, showing a doubling growth trend and achieving the top market share in eight markets [5]

Core Viewpoint - China Tobacco Hong Kong is positioned as the exclusive operational entity within the China Tobacco system, focusing on international business expansion and capital market operations, with a long-term outlook for integrating quality overseas assets and pursuing external acquisition opportunities [1] Group 1: Business Operations - The Chinese tobacco industry operates under a governance system that generates significant revenue, with an expected total industry tax and profit of 16,008 billion yuan in 2024, accounting for 7% of fiscal revenue [1] - The company has exclusive rights to import and export tobacco leaves, with a pricing model that includes a regular import markup of 6% and export procurement price reductions of 1%-4% [2] - The company operates duty-free shops in Thailand and Singapore, covering over 200 duty-free and taxable retail points, with a pricing strategy that includes markups of 1%-5% [2] Group 2: Financial Performance - The company is projected to achieve a revenue and net profit compound annual growth rate (CAGR) of 10% and 12% respectively from 2016 to 2024, indicating a trend of operational growth [1] - The Brazilian business segment has shown significant growth, with revenue increasing from 315 million HKD in 2021 to 1.05 billion HKD in 2024, reflecting a CAGR of 49.4% [3] Group 3: Strategic Development - The company is expected to benefit from the global trend towards new tobacco products, with ongoing efforts to expand its market presence in Southeast Asia, the Russian region, the Middle East, and Europe [3] - The company has signed procurement agreements with various industrial companies in China, focusing on the sale of heated-not-burn (HNB) products to retailers outside of China [3] - The company aims to align its growth strategy with that of international tobacco giants like Philip Morris International, indicating a broad growth potential [4]

Investment Rating - Industry rating is maintained as "Outperform the Market" [7] Core Insights - PMI reported a strong performance in the third quarter of 2025, with revenue reaching $30.3 billion, a year-on-year increase of 7.5%, and gross profit of $20.5 billion, up 12.1% [1] - Smoore achieved record quarterly revenue of $4.197 billion in Q3 2025, marking a 27.2% year-on-year growth [3] - The strong growth in PMI's reduced-risk products, particularly Nicotine Pouches, is a key driver of performance, with shipments increasing by 25.8% year-on-year [2] - Smoore's HNB (Heated Not Burned) business has seen significant growth, supported by successful product launches in international markets [4] Summary by Sections PMI Financial Performance - For the first three quarters of 2025, PMI's revenue was $30.3 billion, with a gross profit of $20.5 billion, and an adjusted diluted EPS of $2.24, reflecting a 17.3% increase [1] - In Q3 alone, revenue was $10.8 billion, with an operating profit of $4.3 billion, showing a 16.7% increase [1] PMI Product Performance - PMI shipped 940 million cans of oral tobacco products in the first three quarters, a 25.8% increase, with Q3 shipments at 313 million cans, up 20.2% [2] - Nicotine Pouches shipments reached 663 million cans in the first three quarters, a 44.0% increase [2] Smoore Financial Performance - Smoore's revenue for the first three quarters was $10.21 billion, a 21.8% increase, with adjusted profit at $1.182 billion, a slight increase of 0.1% [3] - The third quarter revenue of Smoore was a record $4.197 billion, with adjusted profit of $444 million, reflecting a 4.0% year-on-year growth [3] Smoore Product Performance - Smoore's HNB and e-cigarette businesses showed healthy growth, with strategic support for clients leading to increased product launches and compliance with regulations [4] - The introduction of new products and localized marketing efforts have contributed to the growth of Smoore's proprietary brand business [4] Regulatory Environment - Customs authorities in Ningbo and Huangpu seized 265,140 boxes of infringing "ZYN" products, which is expected to strengthen the legitimate supply chain and benefit the compliant oral tobacco industry [5]

Investment Rating - The investment rating for the company is "Buy" and is maintained [12] Core Insights - Smoore International is the largest electronic vaporizer supplier globally, with growth potential unlocked by its technology positioning in HNB (Heated Not Burn) products [3][6] - The company's core business is recovering, benefiting from regulatory shifts in the industry and increasing market share among major clients [3][6] - The HNB business is expected to see significant growth, with a projected annual growth rate in the double digits and a current global penetration rate of less than 6% [3][7] Summary by Sections Introduction - Smoore International leverages its R&D advantages to launch HNB products, marking a new phase in the industry [6][17] - The company has transitioned from a pure equipment supplier to a tobacco business model, opening new growth avenues [6][17] Core Business - The HNB segment is poised for accelerated development, with a low penetration rate and high barriers to entry, indicating substantial growth potential [7][28] - The collaboration with British American Tobacco to launch Glo Hilo combines both companies' strengths, enhancing market competitiveness [7][28] Performance Outlook - The revenue-sharing model for Glo Hilo is expected to yield significant profits, with projections estimating annual profits for Smoore's HNB business to reach 6-7 billion RMB if market penetration increases [8][9] - The U.S. market presents a significant opportunity, with potential market size increases if HNB penetration rises to 15% [8][37] Traditional Business - The U.S. vaping market is expected to grow from $19.81 billion in 2021 to $27.03 billion in 2024, with a CAGR of 11% [9][20] - Regulatory changes in the U.S. are becoming more favorable, allowing for a recovery in the vaporizer business [9][20] Long-term Strategic Direction - The company is diversifying into medical and beauty vaporization, aiming for long-term growth across multiple sectors [10][19]

Core Insights - The global oral tobacco market is projected to reach $11.232 billion in 2024, reflecting a year-on-year growth of 57.57%, and is expected to grow to $25.148 billion by 2028, with a CAGR of 22.32% from 2024 to 2028 [1][2] - The North American and European markets are experiencing high growth rates, while the Asian and African markets are in early stages, indicating significant potential for rapid development in emerging markets [1][2] - The FDA's approval of flavored oral tobacco products is anticipated to act as a catalyst for market growth, potentially increasing the overall market ceiling [1][4] Market Overview - The retail market for oral tobacco is highly concentrated, with Philip Morris International, British American Tobacco, and Altria Group holding market shares of 41.1%, 24.6%, and 13.8% respectively, totaling 79.5% of the market [2] - In 2024, the North American oral tobacco market is expected to reach $8.775 billion, growing by 58.30% year-on-year, while the European market is projected to reach $2.415 billion, with a year-on-year growth of 56.12% [1][2] Company Performance - Philip Morris International's ZYN nicotine pouch sales are projected to be 644 million boxes in 2024, a year-on-year increase of 52.93%, with U.S. sales accounting for 581 million boxes, up 51.49% [2] - British American Tobacco's oral tobacco sales, including brands like Velo and Grizzly, are expected to reach 8.3 billion pouches in 2024, reflecting a year-on-year growth of 55%, with U.S. sales surging by 234% [2] Regulatory Developments - The FDA has authorized the sale of 20 ZYN nicotine pouch products, which are deemed to have lower harmful components compared to traditional cigarettes and most smokeless tobacco products, aligning with public health standards [4] - The approval of flavored products is expected to enhance market growth and expand the market's potential [4] Industry Opportunities - Jin Cheng Pharmaceutical is increasing its production capacity to 200 tons per year, focusing on high-purity nicotine for new tobacco products, which positions the company to benefit from the expanding oral tobacco market [5][6] - The company has received various certifications, including FDA PMTA approval, which enhances its competitive edge in the market [6] Investment Recommendations - Companies to watch in the oral tobacco supply chain include Jin Cheng Pharmaceutical (300233.SZ) and Run Du Co., Ltd. (002923.SZ) [7]

Summary of Conference Call Notes Industry Overview - The Japanese HNB (Heated Not Burned) market has a global penetration rate of 43% in 2024, significantly higher than other countries, indicating substantial growth potential in the new tobacco market [1][3] - The global traditional cigarette market has an HNB penetration rate of less than 6%, highlighting the early development stage of this category [1][8] Market Dynamics - The Japanese new tobacco market is characterized by a "one leader, two strong" structure, with Philip Morris International (PMI) holding a 70% market share, followed by British American Tobacco (BAT) and Japan Tobacco with 15-16% and 14% respectively [1][4] - BAT has shifted some resources from its Hyper product line to Hilo, which is positioned in the high-end market, competing directly with PMI's IQOS [1][10] Product Launch and Promotion - Smoore International launched its new product in Miyagi Prefecture, a region with a high HNB penetration rate of 56%, facilitating product education and promotion [1][5] - The new products are prominently displayed in major convenience stores in Sendai, indicating successful initial promotion [1][5] Product Differentiation - Major brands in Japan have distinct product design philosophies: Japan Tobacco's Pro series uses low-temperature heating, PMI's IQOS is mid-range, and BAT's GLO Helo series targets high-temperature, high-volume consumers [1][6] Global Market Comparison - Other countries lag in HNB development, with penetration rates of 20% in Italy, 18% in South Korea, 16% in Ukraine, and 14% in Poland [1][7] Sales and Distribution - Convenience stores like Seven Eleven have effectively distributed tobacco products, with BAT's PROOM series occupying prime shelf space [1][9] Future Plans and Market Strategy - Smoore plans to fully launch its new products in Japan on September 1 and enter the European market by the end of the year, aiming to validate repurchase rates and consumer acceptance [1][14] - BAT aims to increase its new tobacco revenue share to over 50% within the next decade, reflecting a positive market outlook [1][18] Regulatory and Competitive Challenges - The high entry barriers in the new tobacco industry, coupled with recent regulatory changes in China prohibiting HNB production, pose significant challenges for new entrants [1][17] - Investors should monitor product sales feedback and industry dynamics, as Smoore's competitive advantage is supported by high industry barriers and BAT's brand channel support [1][2][15] Investment Outlook - Investors are encouraged to evaluate the new tobacco industry trends and competitive landscape, as there are positive signs in the Japanese market within a short promotional period [1][20]

Investment Rating - The report maintains an "Accumulate" rating for the industry, indicating a positive outlook for future performance [1]. Core Insights - Philip Morris International (PMI) reported Q2 2025 revenue of $10.1 billion, with an organic year-over-year growth of 6.8%. For the first half of 2025, revenue reached $19.4 billion, up 6.5% year-over-year. The revenue from smoke-free products was $4.2 billion, reflecting a 14.5% organic growth and accounting for 41% of total revenue [4][9]. - The Heat-Not-Burn (HNB) segment continues to grow, with Q2 HNB sales reaching 38.8 billion units, a year-over-year increase of 9.2%. Excluding channel inventory effects, the growth rate was 11.4%. As of Q2 2025, the number of HNB users reached 34 million, with Japan's HNB penetration rate increasing to 48% [4][10]. - British American Tobacco (BAT) reported H1 2025 revenue of £12.569 billion, a 1.8% increase year-over-year at constant exchange rates. The revenue from new tobacco products was £1.651 billion, up 2.4%, representing 18.2% of total revenue [4][10]. Summary by Sections Industry Trends - The global tobacco industry is approaching a market size of nearly $1 trillion, with new tobacco products growing at a faster pace and expected to capture more market share. Major players like PMI and BAT are increasing their focus on smoke-free products, particularly HNB [4][12]. Company Performance - PMI's Q2 2025 performance highlights include a 14.5% increase in smoke-free product revenue and a 100% increase in electronic vapor product sales. The company maintains a full-year sales growth forecast of 10-12% for HNB products [4][9]. - BAT's H1 2025 results show a mixed performance in new tobacco products, with HNB revenue growing modestly while electronic vapor products faced challenges due to regulatory issues [4][10]. Investment Recommendations - The report suggests monitoring companies linked to new tobacco products, such as Smoore International, a leading OEM for BAT's HNB products, and Yingqu Technology, the manufacturer for PMI's IQOS [4][12].

Investment Rating - Industry rating is maintained as "Outperform" [9] Core Insights - The report highlights that reduced-harm products and oral tobacco have become the core growth engines for British American Tobacco (BAT) and Philip Morris International (PMI) [1][3] - BAT's revenue for the first half of 2025 was £12.069 billion, a decrease of 2.2% year-on-year, but a 1.8% increase when excluding currency effects, primarily driven by recovery in the US market [1] - PMI reported a revenue of $19.4 billion for the first half of 2025, reflecting a year-on-year growth of 6.5% [3] Summary by Sections British American Tobacco (BAT) - BAT's operating profit for the first half of 2025 was £5.069 billion, a year-on-year increase of 19.1%, with an operating margin rising by 7.5 percentage points to 42.0% [1] - The diluted EPS for BAT was £2.036, up 1.6% year-on-year [1] - The number of consumers of BAT's reduced-harm products reached 30.5 million, an increase of 1.4 million year-on-year [2] - Modern oral products generated £470 million in revenue, a 38.1% increase year-on-year, with sales volume rising by 42.2% [2] Philip Morris International (PMI) - PMI's gross profit for the first half of 2025 was $13.1 billion, a 12.0% increase year-on-year [3] - The adjusted diluted EPS for PMI was $3.6, reflecting a year-on-year growth of 16.1% [3] - PMI's total shipment volume for the first half of 2025 was 387.9 billion units, a 2.5% increase year-on-year [4] - Reduced-harm product shipments reached 87.9 billion units, a 13.1% increase year-on-year, with 41.5 million consumers globally, an increase of 5 million [4] Regional Performance - In Japan, IQOS covered over 10 million legal-age consumers, with a shipment volume of 13.9 billion units in Q2 2025, a 3.2% increase year-on-year [6] - In the EU, IQOS shipments reached 6 billion units in Q2 2025, a 13.21% increase year-on-year [6] - In South Korea, IQOS shipments were 1.6 billion units in Q2 2025, a 12.8% increase year-on-year [6] Investment Opportunities - The report suggests focusing on the vaping supply chain, including companies like Smoore International and Yihua Healthcare, as well as the tobacco supply chain with companies like China Tobacco Hong Kong and China Boton [7]

Investment Rating - The investment rating for the company is "Positive" [2] Core Insights - The company reported a revenue of $10.14 billion for Q2 2025, representing a year-on-year increase of 7.1%, with a gross margin of 68.3%, up by 4.1 percentage points [2] - Revenue from new tobacco products reached $4.16 billion, showing a year-on-year growth of 15.2%, accounting for 41% of total revenue, with a gross margin of 69.0%, an increase of 4.6 percentage points [2] - The new tobacco segment is viewed as the company's second growth curve, with continuous expansion in product and regional matrices, now available in 97 markets globally, with a total user base of 41.5 million, an increase of 5 million year-on-year [2] - The core product, IQOS, achieved a shipment volume of 39.9 billion units in Q2, a year-on-year increase of 9.2%, with revenue exceeding $3 billion and a market share of 76% in the HNB market [2][3] - The company anticipates a decline of 2% in global cigarette sales for 2025, while maintaining a growth forecast of 12% to 14% for new tobacco products, with HNB growth expected at 10% to 12% [3] Summary by Sections Financial Performance - Q2 2025 revenue was $10.14 billion, up 7.1% year-on-year, with a gross margin of 68.3% [2] - New tobacco revenue was $4.16 billion, a 15.2% increase, with a gross margin of 69.0% [2] Product Performance - IQOS shipments reached 39.9 billion units, a 9.2% increase, with revenue over $3 billion [2][3] - The nicotine pouch segment saw a 23.8% increase in sales, driven by the ZYN brand in the U.S. [3] - VEEV sales doubled in Q2 2025, primarily due to European market contributions [3] Market Outlook - The company expects a 2% decline in cigarette sales for 2025, while new tobacco products are projected to grow by 12% to 14% [3] - The introduction of IQOS ILUMA in the U.S. is anticipated to be a significant change in the new tobacco industry [3]

Investment Rating - The industry investment rating is "Positive" [2] Core Viewpoints - The report emphasizes the current favorable conditions for export chain layout and the rebound of new consumption, suggesting a focus on bottom-cycle assets [2] - The paper highlights various sectors including paper manufacturing, new tobacco, exports, smart glasses, home furnishings, gold and jewelry, two-wheeled vehicles, pets, cross-border e-commerce, retail IP, and mother-baby products, each with specific growth opportunities and recommendations [2][3][4][5][6] Summary by Relevant Sections Paper Manufacturing - The report notes ongoing overseas supply disruptions and domestic efforts to combat "involution," which may drive the paper cycle upward. It suggests monitoring companies like Sun Paper and Xianhe Co. for potential profit recovery [2] New Tobacco - Philip Morris International reported Q2 revenue of $10.14 billion, a year-on-year increase of 7.1%, with new tobacco revenue up 15.2%. The report anticipates a 12%-14% growth in new tobacco shipments for the year [2] Exports - June export data showed a year-on-year increase of 7.0%, with furniture exports up 1.9%. The report suggests focusing on companies with robust overseas production capabilities due to ongoing tariff impacts [2] Smart Glasses - Alibaba's launch of the Quark AI glasses is expected to enhance the industry's influence, with anticipated sales growth driven by improved product capabilities [3] Home Furnishings - Despite industry pressures, companies like IYI Home are experiencing steady growth due to high customer repurchase rates. The report recommends focusing on brands that cater to young consumers [4] Gold and Jewelry - Chow Tai Fook's retail value decreased by 1.9% year-on-year, but the report suggests that the overall market may be nearing a recovery point [4] Two-Wheeled Vehicles - TaoTao's global manufacturing layout is accelerating, with significant production capacity in Vietnam and the U.S. expected to meet market demands [4] Pets - Yuanfei Pet's stock incentive plan targets revenue growth, with a focus on enhancing its overseas supply chain and developing proprietary brands [4] Cross-Border E-commerce - The report highlights ongoing uncertainties regarding tariffs, with leading sellers actively pursuing global expansion strategies [4] Retail IP - The report discusses the growth of Pop Mart and its strategies to enhance brand recognition and operational capabilities [4] Mother-Baby Products - The report notes that children's health care is becoming increasingly competitive, with companies like Kidswant leveraging technology for market advantage [5]